Table 1.
Characteristics of the sample grouped by sarcopenia status
| Robust (58/53.2%) | Probable sarcopenia (35/32.1%) | Sarcopenia (16/14.7%) | P | |
|---|---|---|---|---|
| Age (years) (mean/SD) | 66.1 (9.8) | 73.8 (8.8) | 76.0 (11.2) | < 0.001 |
| Female (n/%) | 30 (51.7) | 24 (68.6) | 9 (56.3) | 0.383 |
| Weight (kg) (median/IQR) | 75.4 (18.7) | 73.8 (19.4) | 57.7 (16.8) | 0.034 |
| Height (cm) (mean/SD) | 169.3 (9.5) | 165.3 (7.7) | 162.9 (9.1) | 0.007 |
| BMI (kg/m2) (median/IQR) | 25.5 (4.8) | 27.8 (4.3) | 23.0 (5.8) | 0.502 |
| 5CST (s) (median/IQR) | 12.0 (2.8) | 19.7 (6.2) | 18.7 (11.1) | < 0.001 |
| HGS (kg) (median/IQR) | 29.0 (14.0) | 20.0 (11.0) | 16.5 (9.0) | < 0.001 |
| ASMM (kg) (median/IQR) | 19.2 (6.9) | 18.6 (6.5) | 14.5 (6.3) | 0.034 |
| Frail (n/%) | 1 (1.7) | 10 (28.6) | 6 (37.5) | < 0.001 |
| Multimorbidity (n/%) | 41 (70.7) | 31 (88.6) | 15 (93.8) | 0.014 |
| Polypharmacy (n/%) | 21 (36.2) | 21 (60.0) | 11 (68.8) | 0.006 |
| Hypertension (n/%) | 26 (44.8) | 18 (51.4) | 9 (56.3) | 0.368 |
| Diabetes (n/%) | 8 (13.8) | 7 (20.0) | 1 (6.3) | 0.756 |
| Cardiovascular Meds (n/%) | 29 (50.0) | 16 (45.7) | 10 (62.5) | 0.564 |
| Psychotropic Meds (n/%) | 11 (19.0) | 18 (51.4) | 7 (43.8) | 0.006 |
| OH30 (n/%) | 14 (24.1) | 13 (37.1) | 7 (43.8) | 0.083 |
BMI, body mass index; 5CST, five-chair stands test; HGS, hand grip strength; ASMM, appendicular skeletal muscle mass; OH30, orthostatic hypotension at 30 s after standing; Meds, medications; SD, standard deviation; n, number; IQR, interquartile range